Literature DB >> 28962171

Role of natural killer cells in liver transplantation treatment of liver cancer.

Wenbin Ji1, Jin Chen1, Yuche Mi1, Guiliang Wang1, Xinjiang Xu1, Weizheng Wang2.   

Abstract

Liver cancer caused by diet or life style is a significant public health problem. Liver transplantation (LT) is a commonly used method of treatment for the liver cancer. The present study aimed to determine whether assessing the net state of natural killer (NK) cell function following LT distinguishes patients at risk for transplantation rejection. A total of 53 patients were involved; all underwent LT for hepatocellular carcinoma with (n=13) or without (n=40) transplantation rejection. The density of interferon-γ (IFN-γ) in blood serum was examined and patients were divided into two groups: Higher (H) and lower (L), on the basis of IFN-γ density. The percentage of NK cells and their producing cytokines was detected using fluorescence-activated cell sorting in peripheral blood and liver samples. As evaluation indexes of liver function, aspartate transaminase (AST) and alanine transaminase (ALT) were detected in blood serum. NK cell activation of the H-group was observed to be higher than the L-group, specifically the expression of NK group 2D, cluster of differentiation 69 and IFN-γ were higher than the L-group. The H-group exhibited a higher level of AST and ALT, which indicates the potential for acute transplantation rejection. The results of the present study indicate that NK cells and NK-derived IFN-γ serve an important function in regulating the rejection of LT and tumor metastasis in response to LT.

Entities:  

Keywords:  hepatocellular carcinoma; interferon-γ; liver cancer; liver transplantation; natural killer cell

Year:  2017        PMID: 28962171      PMCID: PMC5609091          DOI: 10.3892/etm.2017.4748

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

1.  Monitoring serial CD4⁺ T-cell function after liver transplantation can be used to predict hepatocellular carcinoma recurrence.

Authors:  B D Confer; M Choudhary; R Lopez; N N Zein
Journal:  Transplant Proc       Date:  2015 Jan-Feb       Impact factor: 1.066

2.  Evolution of CD4⁺CD25(hi) T cell subsets in Aspergillus-infected liver transplantation recipients reduces the incidence of transplantation rejection via upregulating the production of anti-inflammatory cytokines.

Authors:  T Xing; L Zhong; G Qiu; L Huang; Z Peng
Journal:  Genet Mol Res       Date:  2014-07-04

Review 3.  Markers of acute rejection and graft acceptance in liver transplantation.

Authors:  Giacomo Germani; Kryssia Rodriguez-Castro; Francesco Paolo Russo; Marco Senzolo; Alberto Zanetto; Alberto Ferrarese; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 4.  Liver transplantation: a systematic review of long-term quality of life.

Authors:  Linda S Yang; Leonard L Shan; Akshat Saxena; David L Morris
Journal:  Liver Int       Date:  2014-04-23       Impact factor: 5.828

5.  Comparison of short- and long-term outcomes after early versus late liver retransplantation: a single-center experience.

Authors:  Hideya Kamei; Mamoun Al-Basheer; Jeffrey Shum; Michael Bloch; William Wall; Douglas Quan
Journal:  J Surg Res       Date:  2013-07-31       Impact factor: 2.192

Review 6.  Natural innate and adaptive immunity to cancer.

Authors:  Matthew D Vesely; Michael H Kershaw; Robert D Schreiber; Mark J Smyth
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

7.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

8.  Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry.

Authors:  René Adam; Paul McMaster; John G O'Grady; Denis Castaing; Jurgen L Klempnauer; Neville Jamieson; Peter Neuhaus; Jan Lerut; Mauro Salizzoni; Stephen Pollard; Ferdinand Muhlbacher; Xavier Rogiers; Juan Carlos Garcia Valdecasas; Joaquin Berenguer; Daniel Jaeck; Enrique Moreno Gonzalez
Journal:  Liver Transpl       Date:  2003-12       Impact factor: 5.799

Review 9.  Immunotherapeutic applications of NK cells.

Authors:  Carter T Davis; David Rizzieri
Journal:  Pharmaceuticals (Basel)       Date:  2015-05-25

10.  The global burden of cancer: priorities for prevention.

Authors:  Michael J Thun; John Oliver DeLancey; Melissa M Center; Ahmedin Jemal; Elizabeth M Ward
Journal:  Carcinogenesis       Date:  2009-11-24       Impact factor: 4.944

View more
  1 in total

1.  Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity.

Authors:  Christian Binder; Felix Sellberg; Filip Cvetkovski; Stefan Berg; Erik Berglund; David Berglund
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.